Share: Facebook Twitter LinkedIn
Activity Provided By:

Integritas Communications

The Changing Landscape of IBD: Emerging Concepts in Patient Management

Access Activity

Overview / Abstract:

In the past 2 decades, the introduction of biologic therapies that target underlying disease processes has dramatically changed the treatment of the inflammatory bowel diseases (IBDs), ulcerative colitis and Crohn’s disease. Current biologic therapy with tumor necrosis factor inhibitors and anti-integrins has improved the treatment of IBD flares and maintenance of clinical remission. These agents are, however, limited by primary nonresponse and loss of response in a substantial proportion of patients, disease relapse after cessation of therapy, immunogenicity, and adverse effects such as risk for infection and malignancy.1 As the pathogenesis and treatment of IBD are complex and variable, there is a need to better understand the underlying pathogenic mechanisms and develop drug therapies to target these mechanisms.1

Geared to the needs of gastroenterologists, this IBD eHealth program includes an update on patient assessment and treat-to-target goals, as well as a review of best practices in shared decision-making in treatment decisions for induction and maintenance of remission. In addition, the immunopathogenesis of IBD is discussed in the context of current and emerging targeted therapies for moderate to severe disease.

Expiration

Dec 30, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

1.50

Accreditation

ACCME, CME, CE

Presenters / Authors / Faculty

Raymond K. Cross, Jr., MD, MS; Gary R. Lichtenstein, MD, FACP, FACG, AGAF

Sponsors / Supporters / Grant Providers

This activity is jointly provided by Global Education Group and Integritas Communications

This activity is supported by an educational grant from Gilead Sciences, Inc.

Keywords / Search Terms

Integritas Communications CME, CE, gastroenterologists, IBD, Crohn’s disease, ulcerative colitis Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map